Natural Capsules Ltd. (NATCAPSUQ) Share Price Rises 11.68% as Micro Cap Stock Clears Threshold

Natural Capsules Ltd. Share Price Today stood at Rs 174, up 11.68%. Market capitalisation was Rs 162.21 crore, placing it in the Micro Cap category.

Natural Capsules Ltd. Share Price moved to Rs 174 on 10 August 2026, up Rs 18.2 or 11.68% from the previous close of Rs 155.8, lifting the company’s market capitalisation to Rs 162.21 crore. That made Natural Capsules Ltd. Share Price one of the notable Stocks in News during today’s session, especially because the stock falls in the Micro Cap category and cleared its qualifying price-rise threshold under the event screen tracked by Univest.

What happened today is clear from the verified numbers: the stock opened at Rs 168, traded between Rs 161.15 and Rs 181, and touched a strong intraday high before holding most of the gain at the time of this article. Why is it rising? The supplied data confirms the share price rise and the top gainer status within the screen, but it does not establish a company-specific catalyst. Why is it trending? Because the move was materially above the qualifying bar for its category and came with total traded volume of 76,163 shares.

Important financial metrics also explain why investors may be watching Natural Capsules Ltd. Share Price Today beyond a one-day move. The stock is valued at 0.74 times book value, has a P/E ratio of -7.34, ROE of 19.18, ROCE of 20.75 and EPS of -23.69. Investors tracking Natural Capsules Ltd. Stock News may now monitor whether price action stabilises near today’s range, how valuation compares with the Pharmaceuticals & Drugs industry benchmark, and where the company sits against listed peers. Throughout this Natural Capsules Ltd. Share Price analysis, Univest focuses on what the verified data shows rather than on unsupported explanations.

Natural Capsules Ltd. (NATCAPSUQ) Share Price Today: Price Action Analysis

Natural Capsules Ltd. (NATCAPSUQ) traded at Rs 174. versus the previous close of Rs 155.8, a rise of 11.68%. The stock opened at Rs 168, reached Rs 181, touched Rs 161.15. Reported volume was 9,639.

Natural Capsules Ltd. (NATCAPSUQ) Fundamental Analysis

Natural Capsules Ltd. was valued at a P/E ratio of -7.34x, a P/B ratio of 0.74x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 19.18% and ROCE of 20.75%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs -23.69, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Natural Capsules Ltd. Fundamental Analysis shows a mixed but interesting financial backdrop to today’s move. The company’s market capitalisation of Rs 162.21 crore places it in the smaller end of the listed Healthcare universe, specifically within the Pharmaceuticals & Drugs industry. Size alone does not indicate quality, but it does frame expectations around liquidity, risk and valuation comparability. On valuation, Natural Capsules Ltd. Share Price is trading at a P/E ratio of -7.34 and a P/B ratio of 0.74.

The negative P/E ratio is important because it reflects negative trailing earnings, which is also visible in the reported EPS of -23.69. EPS represents earnings attributable to each share, so a negative value signals that the accounting earnings base behind the multiple remains under pressure. At the same time, the P/B ratio of 0.74 places the stock below one time book value, which means the market price is below the accounting net worth multiple implied by book value-based valuation. In this case, book value per share itself is not separately supplied, but the P/B figure still offers a useful lens on how the market is valuing the business relative to its balance-sheet base.

Profitability ratios add another layer. ROE stands at 19.18 and ROCE at 20.75. ROE measures return generated on shareholder equity, while ROCE shows returns on capital employed across the business. Those are healthy-looking percentages on their own and they suggest that, based on the supplied ratio set, capital efficiency metrics are stronger than what the negative earnings multiple alone might imply. This is why Natural Capsules Ltd. Stock Analysis cannot be reduced to the P/E ratio in isolation.

Dividend yield is 0, which means the current or historical payout relative to price is nil in the supplied dataset. That does not make the stock more or less attractive by itself, but it does mean the present story in Natural Capsules Ltd. Share Price Today is about price movement, valuation and profitability ratios rather than income distribution. Taken together, the numbers show a company with a small market cap, negative EPS, a negative P/E, a low P/B and solid reported ROE and ROCE. That combination neither confirms nor rejects the day’s optimism; instead, it explains why the stock merits closer comparison with its sector benchmark and listed peers. Univest therefore shifts from price movement to relative positioning rather than turning this into a recommendation.

Sector and Industry Context

Natural Capsules Ltd. (NATCAPSUQ) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Natural Capsules Ltd. (NATCAPSUQ) has a P/E ratio of -7.34x, which is below the benchmark median of 26.3x, a difference of -127.91%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Natural Capsules Ltd. (NATCAPSUQ) has a ROE of 19.18%, which is above the benchmark median of 9.93%, a difference of +93.15%. Natural Capsules Ltd. (NATCAPSUQ) has a ROCE of 20.75%, which is above the benchmark median of 12.96%, a difference of +60.11%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Natural Capsules Ltd. Share Price sits within the Healthcare sector and the Pharmaceuticals & Drugs industry, so the most relevant context is the supplied benchmark built on the same industry. That benchmark covers 140 companies for market capitalisation data, 104 companies for P/E comparison, and 139 companies each for P/B, ROE and ROCE. For readers tracking Natural Capsules Ltd. Stock News and broader Market News, this matters because the day’s move should be judged against where the company stands relative to the exact industry it belongs to.

On valuation, the company P/E ratio is -7.34, while the industry benchmark median P/E is 26.3 and the average is 80.76. The benchmark range runs from 3.21 to 3417.8 among the 104 companies with P/E data. Because Natural Capsules Ltd. Share Price carries a negative P/E, it sits outside the positive median and average valuation pattern visible across the peer set. On price-to-book, the company stands at 0.74 versus a benchmark median of 1.83 and average of 2.92, with an industry range from -16 to 59.75 across 139 companies. That places the company below both the median and average P/B for the industry sample.

Profitability ratios compare more favourably. Natural Capsules Ltd. reports ROE of 19.18 against an industry median of 9.93 and average of 7.45. ROCE of 20.75 also stands above the benchmark median of 12.96 and average of 14.33. On market capitalisation, the company’s Rs 162.21 crore is above the benchmark median of Rs 142.44 crore but below the average of Rs 489.44 crore, within a broad industry range of Rs 2.09 crore to Rs 3,032.97 crore.

Put simply, Natural Capsules Ltd. Share Price appears lower than industry norms on P/B, structurally different on P/E because earnings are negative, and stronger than the benchmark on ROE and ROCE. That combination is exactly why the stock is worth comparing directly with named listed peers in the same Pharmaceuticals & Drugs space. Univest uses this industry framing to move from broad sector analysis to company-specific peer comparison.

Peer Comparison

Natural Capsules Ltd. (NATCAPSUQ) has a P/E ratio of -7.34x compared with the displayed peer median of 31.12x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.18% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 20.75% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Natural Capsules Ltd. (NATCAPSUQ) has a market capitalisation of Rs 162.21 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Natural Capsules Ltd. Share Price is best understood by comparing its valuation and profitability with selected listed companies from the same Healthcare and Pharmaceuticals & Drugs universe. The supplied peer set includes larger names such as Dishman Carbogen Amcis Ltd. at Rs 3,032.97 crore market cap, Hikal Ltd. at Rs 2,799.54 crore, Kwality Pharmaceuticals Ltd. at Rs 2,707.2 crore, Beta Drugs Ltd. at Rs 2,631.45 crore and Hester Biosciences Ltd. at Rs 2,057.85 crore. Against these, Natural Capsules Ltd. at Rs 162.21 crore is much smaller in market capitalisation, which is relevant when investors assess liquidity and scale.

On valuation, Natural Capsules Ltd. has a P/E ratio of -7.34. Several peers trade on positive multiples, including Dishman Carbogen Amcis at 31.12, Kwality Pharmaceuticals at 40.2, Beta Drugs at 63.43, Sai Parenteral’s at 176.28, NGL Fine-Chem at 44.02, Venus Remedies at 17.81 and Hester Biosciences at 15.11. The negative P/E makes Natural Capsules Ltd. structurally different from most of those peers. However, its P/B ratio of 0.74 is lower than Hikal’s 2.35, Kwality’s 8.18, Beta Drugs’ 6.27, Panacea Biotec’s 3.03, Sai Parenteral’s 3.26, Solara’s 1.9, NGL Fine-Chem’s 6.43, Venus Remedies’ 3.01 and Hester Biosciences’ 4.52, though Dishman Carbogen Amcis is lower at 0.45.

Profitability tells another story. Natural Capsules Ltd. ROE of 19.18 is above Hikal’s 15.22, Beta Drugs’ 18.65, Sai Parenteral’s 13.9, Solara’s 17.23, Venus Remedies’ 9.85 and Hester Biosciences’ 16.17, while below Kwality Pharmaceuticals’ 28.21 and NGL Fine-Chem’s 27.9. Its ROCE of 20.75 is above Hikal’s 16.15, Sai Parenteral’s 12.97, Solara’s 15.34, Venus Remedies’ 7.89 and Hester Biosciences’ 14.12, while below Beta Drugs’ 22.17, Kwality’s 26.35 and NGL Fine-Chem’s 33.91. For readers following Natural Capsules Ltd. Share Price Update, the peer picture is therefore mixed: the stock is much smaller, cheaper on P/B than most peers, but not uniformly stronger on profitability, and it still carries negative earnings as reflected in EPS and P/E.

Why Investors Are Watching Natural Capsules Ltd.

Natural Capsules Ltd. Share Price has moved into focus because today’s gain was large enough to place it among notable market movers in its category. The stock’s rise was not marginal: it climbed 11.68% to Rs 174, opened above the previous close, traded up to Rs 181 and posted measurable turnover and exchange volume. For investors scanning Bullish Stocks, Momentum Stocks or Stocks Rising Today, the verified data gives enough reasons to watch the stock closely, even though it does not provide a confirmed company-specific catalyst for the move.

• Verified price action: Natural Capsules Ltd. Share Price rose Rs 18.2 from Rs 155.8 to Rs 174, with an intraday range of Rs 161.15 to Rs 181.
• Category relevance: The company is classified as a Micro Cap, and the move cleared the qualifying price-rise threshold attached to that category in the event screen.
• Volume footprint: Total volume reached 76,163 shares, including 9,639 shares on BSE and 66,524 shares on NSE, with turnover at Rs 0.17 crore.
• Fundamental context: Valuation stands at P/E of -7.34 and P/B of 0.74, while ROE is 19.18 and ROCE is 20.75.
• Sector positioning: The company’s ROE and ROCE are above the Pharmaceuticals & Drugs benchmark medians, while its P/B is below the industry median and average.

What should investors monitor next? The practical watchpoints are whether Natural Capsules Ltd. Share Price continues to hold a large part of today’s gain, how the market interprets a negative EPS of -23.69 alongside stronger ROE and ROCE, and whether the stock’s low P/B relative to peers remains a key part of the investment discussion. Univest would also watch how the stock behaves against the broader Healthcare peer set rather than treating one strong session as a complete thesis.

About Natural Capsules Ltd.

Natural Capsules Ltd. operates in the Healthcare sector and is classified within the Pharmaceuticals & Drugs industry. The supplied dataset does not extend into product-level or segment-level detail, so the clearest company overview comes from its market classification and relative standing within the listed industry universe. In practical terms, that places Natural Capsules Ltd. Share Price within a group where investors usually compare valuation, profitability and market capitalisation against other pharmaceutical and drug-related businesses.

The available market data indicates that Natural Capsules Ltd. is a smaller listed company, with a market capitalisation of Rs 162.21 crore. Within the same-industry benchmark of 140 companies, that is above the median market cap of Rs 142.44 crore but below the average of Rs 489.44 crore, which suggests the industry includes a long tail of smaller companies and a handful of much larger ones. Named peers in the supplied comparison set, such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs and Hester Biosciences, are all materially larger by market value.

For readers following Natural Capsules Ltd. Share Price Live and Natural Capsules Ltd. Company News, the company’s identity in the market is therefore tied not just to today’s share price rise but also to its position as a micro-cap participant in the Pharmaceuticals & Drugs space. That makes sector benchmarking especially important when interpreting both the stock’s price behaviour and its financial ratios.

Track Natural Capsules Ltd. Share Price on Univest

Use Natural Capsules Ltd. (NATCAPSUQ) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors tracking Natural Capsules Ltd. Share Price can use Univest to follow live share price moves, daily percentage change, market capitalisation, valuation ratios and broader stock analysis in one place. Natural Capsules Ltd. Share Price Today is only one part of the picture; users also typically monitor P/E, P/B, ROE, ROCE, EPS, dividend yield, 52-week levels and market insights to understand how a stock is positioned within its sector.

Because Natural Capsules Ltd. is part of the Pharmaceuticals & Drugs industry, comparing the stock with benchmark medians and listed peers can be as important as following the latest price action. Univest helps organise those comparisons so readers can track Natural Capsules Ltd. Stock News, market updates and ratio trends without relying on speculation.

Frequently Asked Questions

What is Natural Capsules Ltd. Share Price Today?

Ans. Natural Capsules Ltd. Share Price Today was Rs 174 at the time captured in the dataset. The stock was up Rs 18.2 from the previous close of Rs 155.8, which translates into a single-day gain of 11.68%.

Why is Natural Capsules Ltd. Share Price rising today?

Ans. The verified data confirms that Natural Capsules Ltd. Share Price rose 11.68% today and qualified for the price-rise event screen. However, the supplied figures do not establish any company-specific catalyst behind the move in this session.

What was the intraday range for Natural Capsules Ltd. Share Price?

Ans. Natural Capsules Ltd. Share Price opened at Rs 168, touched a day high of Rs 181 and a day low of Rs 161.15. That trading range shows the stock moved firmly above the previous close during the session.

How much volume was traded in Natural Capsules Ltd. shares today?

Ans. Total traded volume in Natural Capsules Ltd. shares stood at 76,163. Of this, BSE volume was 9,639 and NSE volume was 66,524, while the recorded turnover for the session was Rs 0.17 crore.

What is the market capitalisation of Natural Capsules Ltd.?

Ans. Natural Capsules Ltd. had a market capitalisation of Rs 162.21 crore in the supplied market update. That places the company in the Micro Cap category and above the industry median market cap of Rs 142.44 crore.

Is Natural Capsules Ltd. expensive or cheap on valuation metrics?

Ans. Natural Capsules Ltd. trades at a P/B ratio of 0.74, below the industry median of 1.83 and average of 2.92. Its P/E ratio is -7.34 because the supplied EPS is negative at -23.69.

How do Natural Capsules Ltd. profitability ratios compare with the industry?

Ans. Natural Capsules Ltd. reports ROE of 19.18 and ROCE of 20.75. Both are above the Pharmaceuticals & Drugs industry medians of 9.93 for ROE and 12.96 for ROCE in the supplied benchmark set.

How does Natural Capsules Ltd. compare with peers?

Ans. Natural Capsules Ltd. is much smaller than peers like Dishman Carbogen Amcis, Hikal and Beta Drugs by market cap. Its P/B of 0.74 is lower than most listed peers shown, while ROE and ROCE are mixed comparatively.

Does Natural Capsules Ltd. pay a dividend?

Ans. The supplied data shows a dividend yield of 0 for Natural Capsules Ltd. That means the current dataset does not reflect any yield component in the stock’s present valuation or shareholder return profile.

What should investors monitor after today’s move in Natural Capsules Ltd. Share Price?

Ans. Investors may monitor whether Natural Capsules Ltd. Share Price holds near today’s levels after touching Rs 181, and how the market weighs its low P/B ratio, negative EPS of -23.69, and above-benchmark ROE and ROCE.